HEADER OXIDOREDUCTASE 22-DEC-16 5UCA TITLE CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE-2 IN COMPLEX WITH LAURATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEME OXYGENASE 2; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: RESIDUES 30-242; COMPND 5 SYNONYM: HO-2; COMPND 6 EC: 1.14.14.18; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HMOX2, HO2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HEME OXYGENASE, LAURIC ACID, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR S.LUO,L.TONG REVDAT 4 04-OCT-23 5UCA 1 REMARK REVDAT 3 22-NOV-17 5UCA 1 REMARK REVDAT 2 22-FEB-17 5UCA 1 JRNL REVDAT 1 15-FEB-17 5UCA 0 JRNL AUTH Y.ZHU,S.LUO,Y.SABO,C.WANG,L.TONG,S.P.GOFF JRNL TITL HEME OXYGENASE 2 BINDS MYRISTATE TO REGULATE RETROVIRUS JRNL TITL 2 ASSEMBLY AND TLR4 SIGNALING. JRNL REF CELL HOST MICROBE V. 21 220 2017 JRNL REFN ESSN 1934-6069 JRNL PMID 28132836 JRNL DOI 10.1016/J.CHOM.2017.01.002 REMARK 2 REMARK 2 RESOLUTION. 2.12 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.12 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.65 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 51395 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.810 REMARK 3 FREE R VALUE TEST SET COUNT : 1445 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 24.6518 - 4.5522 0.96 5115 149 0.1634 0.2066 REMARK 3 2 4.5522 - 3.6169 1.00 5114 147 0.1630 0.1979 REMARK 3 3 3.6169 - 3.1607 1.00 5062 150 0.1969 0.2582 REMARK 3 4 3.1607 - 2.8722 1.00 5029 144 0.2169 0.2700 REMARK 3 5 2.8722 - 2.6666 1.00 5022 147 0.2183 0.2793 REMARK 3 6 2.6666 - 2.5096 1.00 5010 143 0.2181 0.2898 REMARK 3 7 2.5096 - 2.3840 1.00 5008 149 0.2144 0.3131 REMARK 3 8 2.3840 - 2.2803 1.00 4967 132 0.2117 0.3092 REMARK 3 9 2.2803 - 2.1926 1.00 4997 147 0.2385 0.2962 REMARK 3 10 2.1926 - 2.1169 0.93 4626 137 0.2531 0.3331 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.580 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.23 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 7098 REMARK 3 ANGLE : 0.797 9528 REMARK 3 CHIRALITY : 0.043 983 REMARK 3 PLANARITY : 0.005 1254 REMARK 3 DIHEDRAL : 19.404 4327 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5UCA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1000225646. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97921 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : LR-DESIGN DETECTOR POSITIONER REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000, DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000, SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51449 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.38500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 5UC8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS (PH 6.5) AND 24% (W/V) REMARK 280 PEG 2000 MONOMETHYL ETHER, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 38.68150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.14850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.96000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 69.14850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.68150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.96000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 17 REMARK 465 GLY A 18 REMARK 465 SER A 19 REMARK 465 SER A 20 REMARK 465 HIS A 21 REMARK 465 HIS A 22 REMARK 465 HIS A 23 REMARK 465 HIS A 24 REMARK 465 HIS A 25 REMARK 465 HIS A 26 REMARK 465 SER A 27 REMARK 465 SER A 28 REMARK 465 GLY A 29 REMARK 465 MET A 30 REMARK 465 ALA A 240 REMARK 465 GLY A 241 REMARK 465 SER A 242 REMARK 465 MET B 17 REMARK 465 GLY B 18 REMARK 465 SER B 19 REMARK 465 SER B 20 REMARK 465 HIS B 21 REMARK 465 HIS B 22 REMARK 465 HIS B 23 REMARK 465 HIS B 24 REMARK 465 HIS B 25 REMARK 465 HIS B 26 REMARK 465 SER B 27 REMARK 465 SER B 28 REMARK 465 GLY B 29 REMARK 465 MET B 30 REMARK 465 GLY B 241 REMARK 465 SER B 242 REMARK 465 MET C 17 REMARK 465 GLY C 18 REMARK 465 SER C 19 REMARK 465 SER C 20 REMARK 465 HIS C 21 REMARK 465 HIS C 22 REMARK 465 HIS C 23 REMARK 465 HIS C 24 REMARK 465 HIS C 25 REMARK 465 HIS C 26 REMARK 465 SER C 27 REMARK 465 SER C 28 REMARK 465 GLY C 29 REMARK 465 MET C 30 REMARK 465 GLY C 241 REMARK 465 SER C 242 REMARK 465 MET D 17 REMARK 465 GLY D 18 REMARK 465 SER D 19 REMARK 465 SER D 20 REMARK 465 HIS D 21 REMARK 465 HIS D 22 REMARK 465 HIS D 23 REMARK 465 HIS D 24 REMARK 465 HIS D 25 REMARK 465 HIS D 26 REMARK 465 SER D 27 REMARK 465 SER D 28 REMARK 465 GLY D 29 REMARK 465 MET D 30 REMARK 465 GLY D 241 REMARK 465 SER D 242 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG D 47 OE2 GLU D 228 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH D 455 O HOH D 490 4555 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 61 58.17 -105.92 REMARK 500 PHE A 94 -27.32 -141.19 REMARK 500 ASN A 120 36.78 -91.10 REMARK 500 ARG A 156 -63.34 -92.80 REMARK 500 PHE A 189 79.15 -102.78 REMARK 500 ASN B 61 48.10 -99.57 REMARK 500 PHE B 94 -30.03 -130.57 REMARK 500 ASN B 120 31.16 -89.51 REMARK 500 ASN B 144 -26.81 -140.28 REMARK 500 GLN B 239 1.32 -69.81 REMARK 500 ARG C 156 -60.27 -90.17 REMARK 500 ASN D 61 49.77 -102.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DAO B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DAO C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DAO D 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5UC8 RELATED DB: PDB REMARK 900 RELATED ID: 5UC9 RELATED DB: PDB DBREF 5UCA A 30 242 UNP P30519 HMOX2_HUMAN 1 213 DBREF 5UCA B 30 242 UNP P30519 HMOX2_HUMAN 1 213 DBREF 5UCA C 30 242 UNP P30519 HMOX2_HUMAN 1 213 DBREF 5UCA D 30 242 UNP P30519 HMOX2_HUMAN 1 213 SEQADV 5UCA MET A 17 UNP P30519 INITIATING METHIONINE SEQADV 5UCA GLY A 18 UNP P30519 EXPRESSION TAG SEQADV 5UCA SER A 19 UNP P30519 EXPRESSION TAG SEQADV 5UCA SER A 20 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS A 21 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS A 22 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS A 23 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS A 24 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS A 25 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS A 26 UNP P30519 EXPRESSION TAG SEQADV 5UCA SER A 27 UNP P30519 EXPRESSION TAG SEQADV 5UCA SER A 28 UNP P30519 EXPRESSION TAG SEQADV 5UCA GLY A 29 UNP P30519 EXPRESSION TAG SEQADV 5UCA MET B 17 UNP P30519 INITIATING METHIONINE SEQADV 5UCA GLY B 18 UNP P30519 EXPRESSION TAG SEQADV 5UCA SER B 19 UNP P30519 EXPRESSION TAG SEQADV 5UCA SER B 20 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS B 21 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS B 22 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS B 23 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS B 24 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS B 25 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS B 26 UNP P30519 EXPRESSION TAG SEQADV 5UCA SER B 27 UNP P30519 EXPRESSION TAG SEQADV 5UCA SER B 28 UNP P30519 EXPRESSION TAG SEQADV 5UCA GLY B 29 UNP P30519 EXPRESSION TAG SEQADV 5UCA MET C 17 UNP P30519 INITIATING METHIONINE SEQADV 5UCA GLY C 18 UNP P30519 EXPRESSION TAG SEQADV 5UCA SER C 19 UNP P30519 EXPRESSION TAG SEQADV 5UCA SER C 20 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS C 21 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS C 22 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS C 23 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS C 24 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS C 25 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS C 26 UNP P30519 EXPRESSION TAG SEQADV 5UCA SER C 27 UNP P30519 EXPRESSION TAG SEQADV 5UCA SER C 28 UNP P30519 EXPRESSION TAG SEQADV 5UCA GLY C 29 UNP P30519 EXPRESSION TAG SEQADV 5UCA MET D 17 UNP P30519 INITIATING METHIONINE SEQADV 5UCA GLY D 18 UNP P30519 EXPRESSION TAG SEQADV 5UCA SER D 19 UNP P30519 EXPRESSION TAG SEQADV 5UCA SER D 20 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS D 21 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS D 22 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS D 23 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS D 24 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS D 25 UNP P30519 EXPRESSION TAG SEQADV 5UCA HIS D 26 UNP P30519 EXPRESSION TAG SEQADV 5UCA SER D 27 UNP P30519 EXPRESSION TAG SEQADV 5UCA SER D 28 UNP P30519 EXPRESSION TAG SEQADV 5UCA GLY D 29 UNP P30519 EXPRESSION TAG SEQRES 1 A 226 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 226 MET ALA ASP LEU SER GLU LEU LEU LYS GLU GLY THR LYS SEQRES 3 A 226 GLU ALA HIS ASP ARG ALA GLU ASN THR GLN PHE VAL LYS SEQRES 4 A 226 ASP PHE LEU LYS GLY ASN ILE LYS LYS GLU LEU PHE LYS SEQRES 5 A 226 LEU ALA THR THR ALA LEU TYR PHE THR TYR SER ALA LEU SEQRES 6 A 226 GLU GLU GLU MET GLU ARG ASN LYS ASP HIS PRO ALA PHE SEQRES 7 A 226 ALA PRO LEU TYR PHE PRO MET GLU LEU HIS ARG LYS GLU SEQRES 8 A 226 ALA LEU THR LYS ASP MET GLU TYR PHE PHE GLY GLU ASN SEQRES 9 A 226 TRP GLU GLU GLN VAL GLN CYS PRO LYS ALA ALA GLN LYS SEQRES 10 A 226 TYR VAL GLU ARG ILE HIS TYR ILE GLY GLN ASN GLU PRO SEQRES 11 A 226 GLU LEU LEU VAL ALA HIS ALA TYR THR ARG TYR MET GLY SEQRES 12 A 226 ASP LEU SER GLY GLY GLN VAL LEU LYS LYS VAL ALA GLN SEQRES 13 A 226 ARG ALA LEU LYS LEU PRO SER THR GLY GLU GLY THR GLN SEQRES 14 A 226 PHE TYR LEU PHE GLU ASN VAL ASP ASN ALA GLN GLN PHE SEQRES 15 A 226 LYS GLN LEU TYR ARG ALA ARG MET ASN ALA LEU ASP LEU SEQRES 16 A 226 ASN MET LYS THR LYS GLU ARG ILE VAL GLU GLU ALA ASN SEQRES 17 A 226 LYS ALA PHE GLU TYR ASN MET GLN ILE PHE ASN GLU LEU SEQRES 18 A 226 ASP GLN ALA GLY SER SEQRES 1 B 226 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 226 MET ALA ASP LEU SER GLU LEU LEU LYS GLU GLY THR LYS SEQRES 3 B 226 GLU ALA HIS ASP ARG ALA GLU ASN THR GLN PHE VAL LYS SEQRES 4 B 226 ASP PHE LEU LYS GLY ASN ILE LYS LYS GLU LEU PHE LYS SEQRES 5 B 226 LEU ALA THR THR ALA LEU TYR PHE THR TYR SER ALA LEU SEQRES 6 B 226 GLU GLU GLU MET GLU ARG ASN LYS ASP HIS PRO ALA PHE SEQRES 7 B 226 ALA PRO LEU TYR PHE PRO MET GLU LEU HIS ARG LYS GLU SEQRES 8 B 226 ALA LEU THR LYS ASP MET GLU TYR PHE PHE GLY GLU ASN SEQRES 9 B 226 TRP GLU GLU GLN VAL GLN CYS PRO LYS ALA ALA GLN LYS SEQRES 10 B 226 TYR VAL GLU ARG ILE HIS TYR ILE GLY GLN ASN GLU PRO SEQRES 11 B 226 GLU LEU LEU VAL ALA HIS ALA TYR THR ARG TYR MET GLY SEQRES 12 B 226 ASP LEU SER GLY GLY GLN VAL LEU LYS LYS VAL ALA GLN SEQRES 13 B 226 ARG ALA LEU LYS LEU PRO SER THR GLY GLU GLY THR GLN SEQRES 14 B 226 PHE TYR LEU PHE GLU ASN VAL ASP ASN ALA GLN GLN PHE SEQRES 15 B 226 LYS GLN LEU TYR ARG ALA ARG MET ASN ALA LEU ASP LEU SEQRES 16 B 226 ASN MET LYS THR LYS GLU ARG ILE VAL GLU GLU ALA ASN SEQRES 17 B 226 LYS ALA PHE GLU TYR ASN MET GLN ILE PHE ASN GLU LEU SEQRES 18 B 226 ASP GLN ALA GLY SER SEQRES 1 C 226 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 C 226 MET ALA ASP LEU SER GLU LEU LEU LYS GLU GLY THR LYS SEQRES 3 C 226 GLU ALA HIS ASP ARG ALA GLU ASN THR GLN PHE VAL LYS SEQRES 4 C 226 ASP PHE LEU LYS GLY ASN ILE LYS LYS GLU LEU PHE LYS SEQRES 5 C 226 LEU ALA THR THR ALA LEU TYR PHE THR TYR SER ALA LEU SEQRES 6 C 226 GLU GLU GLU MET GLU ARG ASN LYS ASP HIS PRO ALA PHE SEQRES 7 C 226 ALA PRO LEU TYR PHE PRO MET GLU LEU HIS ARG LYS GLU SEQRES 8 C 226 ALA LEU THR LYS ASP MET GLU TYR PHE PHE GLY GLU ASN SEQRES 9 C 226 TRP GLU GLU GLN VAL GLN CYS PRO LYS ALA ALA GLN LYS SEQRES 10 C 226 TYR VAL GLU ARG ILE HIS TYR ILE GLY GLN ASN GLU PRO SEQRES 11 C 226 GLU LEU LEU VAL ALA HIS ALA TYR THR ARG TYR MET GLY SEQRES 12 C 226 ASP LEU SER GLY GLY GLN VAL LEU LYS LYS VAL ALA GLN SEQRES 13 C 226 ARG ALA LEU LYS LEU PRO SER THR GLY GLU GLY THR GLN SEQRES 14 C 226 PHE TYR LEU PHE GLU ASN VAL ASP ASN ALA GLN GLN PHE SEQRES 15 C 226 LYS GLN LEU TYR ARG ALA ARG MET ASN ALA LEU ASP LEU SEQRES 16 C 226 ASN MET LYS THR LYS GLU ARG ILE VAL GLU GLU ALA ASN SEQRES 17 C 226 LYS ALA PHE GLU TYR ASN MET GLN ILE PHE ASN GLU LEU SEQRES 18 C 226 ASP GLN ALA GLY SER SEQRES 1 D 226 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 D 226 MET ALA ASP LEU SER GLU LEU LEU LYS GLU GLY THR LYS SEQRES 3 D 226 GLU ALA HIS ASP ARG ALA GLU ASN THR GLN PHE VAL LYS SEQRES 4 D 226 ASP PHE LEU LYS GLY ASN ILE LYS LYS GLU LEU PHE LYS SEQRES 5 D 226 LEU ALA THR THR ALA LEU TYR PHE THR TYR SER ALA LEU SEQRES 6 D 226 GLU GLU GLU MET GLU ARG ASN LYS ASP HIS PRO ALA PHE SEQRES 7 D 226 ALA PRO LEU TYR PHE PRO MET GLU LEU HIS ARG LYS GLU SEQRES 8 D 226 ALA LEU THR LYS ASP MET GLU TYR PHE PHE GLY GLU ASN SEQRES 9 D 226 TRP GLU GLU GLN VAL GLN CYS PRO LYS ALA ALA GLN LYS SEQRES 10 D 226 TYR VAL GLU ARG ILE HIS TYR ILE GLY GLN ASN GLU PRO SEQRES 11 D 226 GLU LEU LEU VAL ALA HIS ALA TYR THR ARG TYR MET GLY SEQRES 12 D 226 ASP LEU SER GLY GLY GLN VAL LEU LYS LYS VAL ALA GLN SEQRES 13 D 226 ARG ALA LEU LYS LEU PRO SER THR GLY GLU GLY THR GLN SEQRES 14 D 226 PHE TYR LEU PHE GLU ASN VAL ASP ASN ALA GLN GLN PHE SEQRES 15 D 226 LYS GLN LEU TYR ARG ALA ARG MET ASN ALA LEU ASP LEU SEQRES 16 D 226 ASN MET LYS THR LYS GLU ARG ILE VAL GLU GLU ALA ASN SEQRES 17 D 226 LYS ALA PHE GLU TYR ASN MET GLN ILE PHE ASN GLU LEU SEQRES 18 D 226 ASP GLN ALA GLY SER HET DAO B 301 14 HET DAO C 301 14 HET DAO D 301 14 HETNAM DAO LAURIC ACID FORMUL 5 DAO 3(C12 H24 O2) FORMUL 8 HOH *414(H2 O) HELIX 1 AA1 ASP A 32 THR A 41 1 10 HELIX 2 AA2 THR A 41 ASN A 50 1 10 HELIX 3 AA3 THR A 51 LYS A 59 1 9 HELIX 4 AA4 LYS A 63 ASN A 88 1 26 HELIX 5 AA5 PHE A 94 TYR A 98 5 5 HELIX 6 AA6 PHE A 99 HIS A 104 1 6 HELIX 7 AA7 ARG A 105 GLY A 118 1 14 HELIX 8 AA8 ASN A 120 VAL A 125 1 6 HELIX 9 AA9 PRO A 128 GLU A 145 1 18 HELIX 10 AB1 LEU A 148 LEU A 175 1 28 HELIX 11 AB2 THR A 184 LEU A 188 5 5 HELIX 12 AB3 ASN A 194 ALA A 208 1 15 HELIX 13 AB4 ASN A 212 GLN A 239 1 28 HELIX 14 AB5 ASP B 32 THR B 41 1 10 HELIX 15 AB6 THR B 41 ASN B 50 1 10 HELIX 16 AB7 THR B 51 GLY B 60 1 10 HELIX 17 AB8 LYS B 63 ASN B 88 1 26 HELIX 18 AB9 PHE B 94 TYR B 98 5 5 HELIX 19 AC1 PHE B 99 HIS B 104 1 6 HELIX 20 AC2 ARG B 105 GLY B 118 1 14 HELIX 21 AC3 ASN B 120 VAL B 125 1 6 HELIX 22 AC4 PRO B 128 GLU B 145 1 18 HELIX 23 AC5 LEU B 148 LYS B 176 1 29 HELIX 24 AC6 THR B 184 LEU B 188 5 5 HELIX 25 AC7 ASN B 194 LEU B 209 1 16 HELIX 26 AC8 ASN B 212 GLN B 239 1 28 HELIX 27 AC9 ASP C 32 THR C 41 1 10 HELIX 28 AD1 THR C 41 ASN C 50 1 10 HELIX 29 AD2 THR C 51 GLY C 60 1 10 HELIX 30 AD3 LYS C 63 ASN C 88 1 26 HELIX 31 AD4 PHE C 94 TYR C 98 5 5 HELIX 32 AD5 PHE C 99 HIS C 104 1 6 HELIX 33 AD6 ARG C 105 GLY C 118 1 14 HELIX 34 AD7 ASN C 120 VAL C 125 1 6 HELIX 35 AD8 PRO C 128 GLU C 145 1 18 HELIX 36 AD9 LEU C 148 LYS C 176 1 29 HELIX 37 AE1 THR C 184 LEU C 188 5 5 HELIX 38 AE2 ASN C 194 LEU C 209 1 16 HELIX 39 AE3 ASN C 212 ALA C 240 1 29 HELIX 40 AE4 ASP D 32 THR D 41 1 10 HELIX 41 AE5 THR D 41 ASN D 50 1 10 HELIX 42 AE6 THR D 51 LYS D 59 1 9 HELIX 43 AE7 LYS D 63 ASN D 88 1 26 HELIX 44 AE8 PHE D 94 TYR D 98 5 5 HELIX 45 AE9 PHE D 99 HIS D 104 1 6 HELIX 46 AF1 ARG D 105 GLY D 118 1 14 HELIX 47 AF2 ASN D 120 VAL D 125 1 6 HELIX 48 AF3 PRO D 128 GLU D 145 1 18 HELIX 49 AF4 LEU D 148 LEU D 175 1 28 HELIX 50 AF5 THR D 184 LEU D 188 5 5 HELIX 51 AF6 ASN D 194 LEU D 209 1 16 HELIX 52 AF7 ASN D 212 ALA D 240 1 29 SITE 1 AC1 5 GLU B 49 LEU B 74 ARG B 156 TYR B 187 SITE 2 AC1 5 PHE B 234 SITE 1 AC2 4 GLU C 49 VAL C 54 LEU C 74 ARG C 156 SITE 1 AC3 8 VAL D 54 ALA D 70 THR D 77 ARG D 156 SITE 2 AC3 8 TYR D 187 ASN D 230 PHE D 234 HOH D 404 CRYST1 77.363 83.920 138.297 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012926 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011916 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007231 0.00000